Michael H. Rosenbloom, MD
Former Director, Center for Memory and Aging

Joined the Institute: 2010

Education and training: MD, Columbia University, College of Physicians and Surgeons

Overview/research interests: Pittsburgh Compound B imaging in atypical presentations of Alzheimer’s disease, rapidly progressive dementia, early diagnosis of Alzheimer’s disease, intranasal insulin in Alzheimer’s Disease, cognitive screening.

Current research activities and funding:

• Principal investigator (PI) for A Double-Blinded, Placebo-Controlled Single Dose Study of the Safety and Efficacy of Glulisine on Cognitive Function and Memory in Individuals Diagnosed with Probable Mild to Moderate Alzheimer’s Disease/Intranasal Insulin Study
• PI for “Feasibility of the Mini-Cog as a Standardized Cognitive Screen in HealthPartners Patients Aged 70 and Older”
• PI for “A Phase 3 Randomized, Double-Blind Placebo-Controlled Study of the Safety and Effectiveness of Immune Globulin Intravenous (Human) 10% Solution (IGIV 10%) for the Treatment of Mild to Moderate Alzheimer’s Disease (AD)”